Status:
COMPLETED
MAPS & ITEC Cohorts: 6-8 Years Follow-up
Lead Sponsor:
University of Southampton
Collaborating Sponsors:
Isle of Wight NHS Trust
Conditions:
Immunotherapy
Allergy and Immunology
Eligibility:
All Genders
5-9 years
Phase:
PHASE2
Brief Summary
This study represents the follow-up, age 6-8 years, of children recruited at birth into two cohorts. The first cohort, the Mite Allergen Prevention Study (MAPS) was a double-blind, randomized controll...
Detailed Description
There is an epidemic of allergic disease in childhood and current preventative strategies have failed to demonstrate effectiveness outside of isolated trials. In a previous study, the efficacy of subl...
Eligibility Criteria
Inclusion
- •Inclusion in original study cohorts at birth
- •≥2 first-degree relatives with allergic disease (food allergy, asthma, eczema, rhinoconjunctivitis)
Exclusion
- Not included in the original study cohorts
- Skin-prick test positive to any allergen (HDM, cat, grass pollen, peanut, egg and milk) age 5 months
Key Trial Info
Start Date :
September 15 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 15 2019
Estimated Enrollment :
263 Patients enrolled
Trial Details
Trial ID
NCT03763630
Start Date
September 15 2017
End Date
January 15 2019
Last Update
October 4 2021
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Southampton NHS Foundation Trust
Southampton, Hampshire, United Kingdom, SO16 6YD
2
David Hyde Asthma and Allergy Centre
Newport, Isle of White, United Kingdom, PO30 5TG